SUPPLEMENTARY INFORMATION

Similar documents
Correlated mutations in the four influenza proteins essential for viral RNA synthesis, host adaptation, and virulence: NP, PA, PB1, and PB2

Influenza viruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Viral determinants of influenza A virus host range

Relative activity (%) SC35M

Characterization of the 1918 influenza virus polymerase genes

Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid.

Patricia Fitzgerald-Bocarsly

Modeling the Antigenic Evolution of Influenza Viruses from Sequences

Protein Modeling Event

Evolution of influenza

What is influenza virus? 13,000 base RNA genome: 1/ the size of the human genome


Impact of Amino Acid Mutations in PB2, PB1-F2, and NS1 on the Replication and Pathogenicity of Pandemic (H1N1) 2009 Influenza Viruses

Supplementary Figure 1 Weight and body temperature of ferrets inoculated with

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

Polyomaviridae. Spring

Mutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey

Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E,

Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication

ARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za

Reassortment of influenza A virus genes linked to PB1 polymerase gene

Lecture 2: Virology. I. Background

Bioinformation Volume 5

To test the possible source of the HBV infection outside the study family, we searched the Genbank

Influenza A Virus Multiplication and the Cellular SUMOylation System

Pandemic Influenza influenza epidemic: realization of a worst-case scenario

Flu, Avian Flu and emerging aspects (H1N1 resistance)

Supplementary Fig. S1. Schematic diagram of minigenome segments.

The accumulation of influenza A virus segment 7 spliced mrnas is regulated by the NS1 protein

Public health relevant virological features of Influenza A(H7N9) causing human infection in China

Review. Elise Biquand 1,2 Caroline Demeret 1,2

Avian Influenza Virus H7N9. Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences

Qinfang Liu, Chuanling Qiao, Henju Marjuki, Bhupinder Bawa, Jingqun Ma, Stephane Guillossou, Richard J. Webby, Jürgen A.

Cristina Cassetti, Ph.D.

Coronaviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

From Mosquitos to Humans: Genetic evolution of Zika Virus

numbe r Done by Corrected by Doctor

Human Genome: Mapping, Sequencing Techniques, Diseases

Lecture 19 Evolution and human health

Identification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist

TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?

Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University

Build a better chicken?

number Done by Corrected by Doctor Ashraf

ISG15 sirna # Ctrl sirna+ifn+wt. Virus titer (Pfu/ml) hours post infection. d USP18 sirna #2 IFN

Nature Medicine: doi: /nm.4322

Dengue NS5 Global Consensus Sequence Development to Find Conserved Region for Antiviral Drug Development

Final Report. Identification of Residue Mutations that Increase the Binding Affinity of LSTc to HA RBD. Wendy Fong ( 方美珍 ) CNIC; Beijing, China

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

SUPPLEMENTARY INFORMATION

Virus and Prokaryotic Gene Regulation - 1

Study the Evolution of the Avian Influenza Virus

Emerging Viruses. Part IIb Follow Up from Part I Vaccines and Inhibitors

Last time we talked about the few steps in viral replication cycle and the un-coating stage:

Phylogenetic Methods

An Exploration to Determine if Fab Molecules are Efficacious in Neutralizing Influenza H1 and H3 Subtypes. Nick Poulton June September 2012

Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS

7.014 Problem Set 7 Solutions

Transcription and RNA processing

Although the natural reservoirs of influenza A viruses lacking

Overview: Chapter 19 Viruses: A Borrowed Life

A Novel Duplex Real-Time Reverse-Transcription PCR Assay for the Detection of Influenza A and the Novel Influenza A(H1N1) Strain

Translation. Host Cell Shutoff 1) Initiation of eukaryotic translation involves many initiation factors

33VASTVNGATSANNHGEPPS51PADARPR58

RNA (Ribonucleic acid)

Revisiting the Definition of Living Thing

October 26, Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell

MOLECULAR CELL BIOLOGY

Influenza Genome Sequencing Project Proposal

Lecture 18 Evolution and human health

Unidirectional RNA polymerase I polymerase II transcription system for the generation of influenza A virus from eight plasmids

Emergence of distinct avian-like influenza A H1N1 viruses in pigs in Ireland and their reassortment with cocirculating H3N2 viruses

HS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations.

The RNA Polymerase of Influenza Virus, Bound to the 5 End of Virion RNA, Acts in cis To Polyadenylate mrna

P450 CYCLE. All P450s follow the same catalytic cycle of;

Genetic information flows from mrna to protein through the process of translation

Viral reproductive cycle

Nanoparticulate Vaccine Design: The VesiVax System

Host Dependent Evolutionary Patterns and the Origin of 2009 H1N1 Pandemic Influenza

Bioinformation by Biomedical Informatics Publishing Group

Section 6. Junaid Malek, M.D.

Diagnosis of infectious diseases and confirmation of diagnosis. Molecular epidemiology of emerging/re-emerging pathogens

Where Health Care Meets Policy. with Dr. Mike Magee

Avian influenza Avian influenza ("bird flu") and the significance of its transmission to humans

Lecture 2 Evolution in action: the HIV virus

L I F E S C I E N C E S

Islamic University Faculty of Medicine

Insulin mrna to Protein Kit

Oncolytic virus strategy

Bio 111 Study Guide Chapter 17 From Gene to Protein

SUPPLEMENTARY INFORMATION

Immunogenicity of Avian Influenza H7N9 Virus in Birds

Molecular Biology (BIOL 4320) Exam #2 May 3, 2004

Alpha thalassemia mental retardation X-linked. Acquired alpha-thalassemia myelodysplastic syndrome

BIOLOGY. Viruses CAMPBELL. Reece Urry Cain Wasserman Minorsky Jackson. Lecture Presentation by Nicole Tunbridge and Kathleen Fitzpatrick TENTH EDITION

Different De Novo Initiation Strategies Are Used by Influenza Virus RNA Polymerase on Its crna and Viral RNA Promoters during Viral RNA Replication

Chapter 6- An Introduction to Viruses*

Phenomena first observed in petunia

Transcription and RNA processing

Influenzavirus. Influenzavirus 10/27/15. Lord Randolphs report from Queen Marys trip to Scotland in 1562

Transcription:

doi:10.1038/nature14008 Supplementary Figure 1. Sequence alignment of A/little yellow-shouldered bat/guatemala/060/2010 (H17N10) polymerase with that of human strain A/Victoria/3/75(H3N2). The secondary structure of the bat polymerase is indicated above. White on red background indicates identical residues. Red lettering indicates similar residues. Figure prepared with Espript 3.0 (http://espript.ibcp.fr/espript/cgi-bin/espript.cgi). a. PA subunit b. PB1 subunit c. PB2 subunit WWW.NATURE.COM/NATURE 1

RESEARCH SUPPLEMENTARY INFORMATION Supplementary Figure 1. a. PA subunit 2 WWW.NATURE.COM/NATURE

RESEARCH b. PB1 subunit WWW.NATURE.COM/NATURE 3

RESEARCH SUPPLEMENTARY INFORMATION c. PB2 subunit 4 WWW.NATURE.COM/NATURE

RESEARCH 1. Discussion of previous studies of the vrna binding site on influenza polymerase. Various studies have sought to identify the vrna 3 and 5 end binding sites. Using PB1 deletion mutants it was found that the N-terminal 83 residues and C-terminal residues beyond 493 of PB1 were involved in 5 end binding 1. Using a crosslinking approach with thio-u substituted RNA, region 560-574 (notably 571-RR-572) of PB1 was identified to be involved in 5 end binding (thio-u at position 15) and region 249-256 (notably F251, F254) in 3 end binding (thio-u at position 10) 2. In another study, the previous results on 3 end binding were not confirmed and region 233-249 (notably R233, R238) of PB1 was proposed to be involved in 5 end binding and R239, R249 in duplex binding 3. This study noted that PA also binds the promoter and PB2 is only involved in 3 end binding. Mutations of PB1 C- terminal residues K669, R670 and R672 were shown to be important in regulation of transcription by reducing promoter binding 4. All numbering is for human/avian A strains. In the light of the current structure it is interesting that very few of the residues cited above are directly involved in promotor binding. PB1 R571 is 16 Å from the promoter duplex region. It is possible that this could cross-link to thio-u at position 15 on 5 end since 11-15 of 5 end would be very flexible in the absence of 3 end to form the duplex. PB1 F251 and F254 are buried and their mutation would likely disrupt the fold. R233, R238 are on the finger-tips loop close, but not directly interacting, with the 5 end hook (Extended Data Figure 6a); their mutation would likely disrupt 5 end binding. R239 (finger-tips loop) is in the NTP channel (Extended Data Figure 6a) and R249 likely binds the template in the PB1 cavity (Figure 4a). PB1 R672 is involved in 3 end binding (Extended Data Figure 6). Although in the structure 5 adenosine A1 only has a monophosphate, conserved basic residues PA K328 and PB1 K360 and H363 (bat numbering) could plausibly interact with a triphosphate on this nucleotide. Interestingly, the recently reported 5 end derived small virus WWW.NATURE.COM/NATURE 5

RESEARCH SUPPLEMENTARY INFORMATION generated RNAs 5 were found to depend on PA R566 (bat R561, Fig. 5d) and to a lesser extent on PA K328 (bat K328) and K539 (bat K534) for polymerase binding suggesting that these svrnas bind in the same manner as the genomic 5 end. 2. Discussion of putative host-specific residues in influenza polymerase. There is considerable interest in understanding the role of polymerase residues that have been implicated in host adaptation, notably between avian and human influenza A strains (reviewed in 6 ). Residue substitutions potentially involved in inter-species transmission have been identified from naturally occurring sequences by bioinformatics analysis 7,8 or by host adaption experiments using cells 9-11 or mice 12. Such mutations typically have a neutral effect in avian cells but enhance polymerase activity in mammalian cells, without necessarily augmenting pathogenicity. The most well characterised host adaptation residues occur in the PB2 627-NLS domain with avian/mammalian preferences V613T, E627K, D701N, K702R and S714R. Other implicated PB2 residues are E158G and T271A. In PA, substitutions T85I, G186S, L336M, P400L, M423I, V476A, T552S and V630E have been implicated and in PB1 N375S. All numbering is for human/avian A strains. It is fair to say that the mechanism by which these substitutions cause observed altered viral tropism is unknown for most of these substitutions 6 although those on the PB2-NLS domain have been associated with interactions with host importins 13,14. Since the positions of implicated residues can henceforth be mapped onto the full polymerase structure, an initial distinction that can now be made is between those residues (type 1) that are more likely to affect the intrinsic rate of polymerase functions (which could be important for species dependent physiological reasons) and others (type 2), which because of their surface location, possibly act through direct interaction with other viral or host factors (of which there are numerous putative contenders 15-19 ). For the PB2 627-NLS domain 6 WWW.NATURE.COM/NATURE

RESEARCH residues the complete structure does not add much new insight except to say that the double domain and residue 627 in particular (S627 in bat, K627 in human A and B strains, E in avian) is distant from the polymerase catalytic center but possibly on the exit path of newly synthesised RNA 20. Neither PB2 residues 158 (a conserved glutamate in A and B strains) and 271 (I in bat, S in human, T in avian) are in surface exposed positions and thus could be of type 1. Residue 158 is in the PB2 helical lid domain at the N-terminus of helix α9. The lid domain is implicated in channelling of capped primer into the polymerase active site but is also likely to change conformation during elongation 20. Residue 271 is at the interface between the PB2 mid and 627 domains. Thus both these substitutions could affect polymerase activity through altering dynamic interactions of polymerase sub-domains domains or with RNA. This is similarly the case for PA positions 85 (at the endonuclaease- PB1Cter interface), 186 (at the beginning of the flexible PA-linker), 400 (in the PA-arch near the 5 end binding site) and 476 (close the separation point of 3 and 5 strands). On the other hand, a clear example of a potential type 2 residue is PA 552 (T in bat, and avian, S in human) which is on the very prominent and exposed PA 550-loop at the bottom of the polymerase (Fig. 1a) and similarly PA residues 336 and 630 are surface exposed. PB1 residue 375 (D in bat and S in most other flu strains) is in an exposed surface position not far from the promoter binding site. Clearly further biochemical and structural studies of polymerase in different conformations and eventually with host factors is required to determine the exact role of these putative host-specific residues. WWW.NATURE.COM/NATURE 7

RESEARCH SUPPLEMENTARY INFORMATION Supplementary References. 1 Gonzalez, S. & Ortin, J. Characterization of influenza virus PB1 protein binding to viral RNA: two separate regions of the protein contribute to the interaction domain. Journal of virology 73, 631-637 (1999). 2 Li, M. L., Ramirez, B. C. & Krug, R. M. RNA-dependent activation of primer RNA production by influenza virus polymerase: different regions of the same protein subunit constitute the two required RNA-binding sites. The EMBO journal 17, 5844-5852 (1998). 3 Jung, T. E. & Brownlee, G. G. A new promoter-binding site in the PB1 subunit of the influenza A virus polymerase. The Journal of general virology 87, 679-688 (2006). 4 Kerry, P. S., Willsher, N. & Fodor, E. A cluster of conserved basic amino acids near the C-terminus of the PB1 subunit of the influenza virus RNA polymerase is involved in the regulation of viral transcription. Virology 373, 202-210, doi:10.1016/j.virol.2007.11.030 (2008). 5 Perez, J. T. et al. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proceedings of the National Academy of Sciences of the United States of America 107, 11525-11530, doi:10.1073/pnas.1001984107 (2010). 6 Cauldwell, A. V., Long, J. S., Moncorge, O. & Barclay, W. S. Viral determinants of influenza A virus host range. The Journal of general virology 95, 1193-1210, doi:10.1099/vir.0.062836-0 (2014). 7 Taubenberger, J. K. et al. Characterization of the 1918 influenza virus polymerase genes. Nature 437, 889-893 (2005). 8 Tamuri, A. U., dos Reis, M., Hay, A. J. & Goldstein, R. A. Identifying Changes in Selective Constraints: Host Shifts in Influenza. PLoS Comput Biol 5, e1000564 (2009). 9 Bussey, K. A. et al. PA residues in the 2009 H1N1 pandemic influenza virus enhance avian influenza virus polymerase activity in mammalian cells. Journal of virology 85, 7020-7028, doi:10.1128/jvi.00522-11 (2011). 10 Bussey, K. A., Bousse, T. L., Desmet, E. A., Kim, B. & Takimoto, T. PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. Journal of virology 84, 4395-4406, doi:10.1128/jvi.02642-09 (2010). 11 Mehle, A., Dugan, V. G., Taubenberger, J. K. & Doudna, J. A. Reassortment and mutation of the avian influenza virus polymerase PA subunit overcome species barriers. Journal of virology 86, 1750-1757, doi:10.1128/jvi.06203-11 (2012). 12 Gabriel, G. et al. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proceedings of the National Academy of Sciences of the United States of America 102, 18590-18595 (2005). 13 Tarendeau, F. et al. Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit. Nature structural & molecular biology 14, 229-233 (2007). 14 Resa-Infante, P. & Gabriel, G. The nuclear import machinery is a determinant of influenza virus host adaptation. BioEssays : news and reviews in molecular, cellular and developmental biology 35, 23-27, doi:10.1002/bies.201200138 (2013). 15 Jorba, N. et al. Analysis of the interaction of influenza virus polymerase complex with human cell factors. Proteomics 8, 2077-2088 (2008). 8 WWW.NATURE.COM/NATURE

RESEARCH 16 Munier, S., Rolland, T., Diot, C., Jacob, Y. & Naffakh, N. Exploration of binary virus-host interactions using an infectious protein complementation assay. Molecular & cellular proteomics : MCP 12, 2845-2855, doi:10.1074/mcp.m113.028688 (2013). 17 Karlas, A. et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463, 818-822, doi:10.1038/nature08760 (2010). 18 Mehle, A. & Doudna, J. A. A host of factors regulating influenza virus replication. Viruses 2, 566-573, doi:10.3390/v2020566 (2010). 19 Bradel-Tretheway, B. G. et al. Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors. Journal of virology 85, 8569-8581, doi:10.1128/jvi.00496-11 (2011). 20 Reich, S. et al. Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Submitted (2014). WWW.NATURE.COM/NATURE 9